Kevin founded Biorez in 2016 with a mission to improve tendon and ligament healing, then went to work building a world-class team of medical device professionals and surgeon advisors. Together, they ultimately invented, developed, and commercially launched the BioBrace implant in the US Sports Medicine market following FDA clearance in May of 2021. BioBrace was immediately recognized by surgeon customers and the broader industry for its unique combination of improving strength and healing for tendon and ligament repairs. Biorez was acquired by Conmed Corporation in August 2022 in a deal valued up to $250 million.